14-67626868-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001172.4(ARG2):​c.184+5902T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.398 in 152,118 control chromosomes in the GnomAD database, including 14,595 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 14595 hom., cov: 32)

Consequence

ARG2
NM_001172.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.03

Publications

2 publications found
Variant links:
Genes affected
ARG2 (HGNC:664): (arginase 2) Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exists (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type II isoform encoded by this gene, is located in the mitochondria and expressed in extra-hepatic tissues, especially kidney. The physiologic role of this isoform is poorly understood; it is thought to play a role in nitric oxide and polyamine metabolism. Transcript variants of the type II gene resulting from the use of alternative polyadenylation sites have been described. [provided by RefSeq, Jul 2008]
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.678 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARG2NM_001172.4 linkc.184+5902T>C intron_variant Intron 2 of 7 ENST00000261783.4 NP_001163.1
LOC124903331XR_007064218.1 linkn.3594A>G non_coding_transcript_exon_variant Exon 2 of 2
GPHNXM_047430879.1 linkc.1313-108327T>C intron_variant Intron 14 of 14 XP_047286835.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARG2ENST00000261783.4 linkc.184+5902T>C intron_variant Intron 2 of 7 1 NM_001172.4 ENSP00000261783.3
ARG2ENST00000556491.1 linkn.182+5902T>C intron_variant Intron 2 of 3 5
ARG2ENST00000557120.5 linkn.226+5902T>C intron_variant Intron 2 of 4 2

Frequencies

GnomAD3 genomes
AF:
0.397
AC:
60415
AN:
152000
Hom.:
14547
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.684
Gnomad AMI
AF:
0.138
Gnomad AMR
AF:
0.374
Gnomad ASJ
AF:
0.299
Gnomad EAS
AF:
0.453
Gnomad SAS
AF:
0.358
Gnomad FIN
AF:
0.289
Gnomad MID
AF:
0.421
Gnomad NFE
AF:
0.252
Gnomad OTH
AF:
0.412
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.398
AC:
60536
AN:
152118
Hom.:
14595
Cov.:
32
AF XY:
0.397
AC XY:
29489
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.684
AC:
28384
AN:
41474
American (AMR)
AF:
0.375
AC:
5727
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.299
AC:
1036
AN:
3468
East Asian (EAS)
AF:
0.453
AC:
2351
AN:
5192
South Asian (SAS)
AF:
0.361
AC:
1738
AN:
4820
European-Finnish (FIN)
AF:
0.289
AC:
3055
AN:
10578
Middle Eastern (MID)
AF:
0.422
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
0.252
AC:
17115
AN:
67980
Other (OTH)
AF:
0.416
AC:
880
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1677
3354
5030
6707
8384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.342
Hom.:
1426
Bravo
AF:
0.420
Asia WGS
AF:
0.432
AC:
1502
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.6
DANN
Benign
0.78
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4902501; hg19: chr14-68093585; API